News
Cryoport Announces Agreement to Acquire MVE Biological Solutions from...
Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced it has signed an agreement to acquire MVE Biological...
News
Pfizer and BioNTech Share Positive Early Data on Lead...
Pfizer Inc. and BioNTech SE shared additional Phase 1 safety and immunogenicity data from their ongoing U.S. study of the BNT162 mRNA-based vaccine program against...
News
Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding...
Bristol Myers Squibb and Forbius, a privately held, clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases,...
Drug Research
Quanticate Announces new Partnership with Antev Ltd
Quanticate is pleased to partner with Antev Limited on a Phase II, Open-Label, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix Trifluoroacetate,...
News
UAEs Mubadala invests in US pharma business
Abu Dhabi’s sovereign wealth fund, Mubadala, and New York-based private equity group Kohlberg will take a majority stake in the pharmaceutical company PCI Pharma Services,...
News
Frontida BioPharma Completes Facility Expansion
Frontida BioPharm, Inc. announced the completion of a facility expansion to their oral solid dose manufacturing operations with the commissioning of a Highly Potent Compound...
News
Symbiosis confirms commitment to growth strategy with key appointment
Symbiosis Pharmaceutical Services (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile manufacture of vaccines, pharmaceuticals and biopharmaceuticals, and headquartered in Stirling, UK, has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.














